Bellevue Group AG

Q2 2019 13F Holdings Report, Stock Holdings

Signature - Title
Michael Hutter - CFO
Location
Kuesnacht, Switzerland
Holdings as of
30 Jun 2019
Value $
$5,856,751,000
Num holdings
201
Filing time
14 Aug 2019, 14:28:26 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IONS, INCY, NBIX, VRTX, and SAGE.
Previous filing
Q1 2019 - 15 May 2019
Next filing
Q3 2019 - 14 Nov 2019
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q2 compared to 2019 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Michael Hutter CFO Kuesnacht, Switzerland 13 Aug 2019

Other Included Managers (6):

Num Name Location File Number
1 BB BIOTECH AG Schaffhausen 028-06964
2 BIOTECH FOCUS N. V. Willemstad, Netherlands Antilles 028-11193
3 BIOTECH INVEST N V Willemstad, Netherlands Antilles 028-11191
4 BIOTECH TARGET N V Willemstad, Netherlands Antilles 028-11189
5 BIOTECH GROWTH N V Willemstad, Netherlands Antilles 028-11194
6 Bellevue Asset Management AG Zurich 028-16892